Palace: Aged 40-59 may get preference in A4 vaccination group | Inquirer News

Palace: Aged 40-59 may get preference in A4 vaccination group

By: - Reporter / @KAguilarINQ
/ 12:51 PM May 28, 2021

(FILE) Pasay City residents troop to the city government’s Giga Vaccination center at SM Mall of Asia to receive the first dose of AstraZeneca vaccine. —RICHARD A. REYES

MANILA, Philippines — Local government units (LGUs) may give preference to persons who are 40 to 59 years old once the vaccination of essential workers or the A4 priority group starts, Malacañang said Friday.

“For Priority Group A4, LGUs may give preference for persons aged 40 to 59 years old over 18 to 39 years old,” presidential spokesperson Harry Roque said in a statement.

Article continues after this advertisement

As the government prepares for the vaccination of the A4 group eyed in June, Roque noted LGUs must still the inoculation of prioritizing health workers (A1), senior citizens (A2), and persons with comorbidities (A3) “by establishing special lanes and/or vaccination centers.”

FEATURED STORIES

The COVID-19 task force already simplified the criteria for vaccination of the A4 group.

The vaccination of A4 will first focus on the so-called NCR Plus 8 comprising Metro Manila, Bulacan, Cavite, Rizal, Laguna, Pampanga, Batangas, Cebu, and Davao.

/MUF
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: A4 group, coronavirus Philippines, COVID-19 Vaccine, Malacañang, Palace, Vaccination

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.